Literature DB >> 2567278

Close linkage of MEN2A with RBP3 locus in Japanese kindreds.

M Yamamoto1, S Takai, T Miki, K Motomura, M Okazaki, I Nishisho, H Tateishi, A Miyauchi, T Honjo, A J Pakstis.   

Abstract

The gene responsible for multiple endocrine neoplasia type 2A (MEN2A) has recently been assigned to the pericentromeric region of chromosome 10 in European Caucasian kindreds by linkage analysis using a DNA marker, interstitial retinol-binding protein 3 (RBP3). We have found tight linkage between the MEN2A and RBP3 loci in Japanese MEN2A kindreds. The maximum lod score is 5.19 at a recombination fraction of 0.00. This result suggests that mutation of a certain gene close to RBP3 is responsible for MEN2A irrespective of ethnic backgrounds.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567278     DOI: 10.1007/BF00291173

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

2.  Multiple endocrine neoplasia type 2 syndromes in Japan.

Authors:  S Takai; A Miyauchi; H Matsumoto; T Ikeuchi; T Miki; K Kuma; Y Kumahara
Journal:  Henry Ford Hosp Med J       Date:  1984

3.  Screening multiple endocrine neoplasia type 2A families using DNA markers.

Authors:  H Sobol; A Salvetti; C Bonnardel; G M Lenoir
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

4.  Bgl II RFLP recognized by a human IRBP cDNA localized to chromosome 10.

Authors:  G I Liou; Y Li; C Wang; S L Fong; S Bhattacharya; C D Bridges
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

5.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.

Authors:  C G Mathew; K S Chin; D F Easton; K Thorpe; C Carter; G I Liou; S L Fong; C D Bridges; H Haak; A C Kruseman
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

  5 in total
  7 in total

1.  Genetic analysis of 24 French families with multiple endocrine neoplasia type 2A.

Authors:  S A Narod; M F Lavoué; K Morgan; C Calmettes; H Sobol; P J Goodfellow; G M Lenoir
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

2.  Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Authors:  S A Wells; D D Chi; K Toshima; L P Dehner; C M Coffin; S B Dowton; J L Ivanovich; M K DeBenedetti; W G Dilley; J F Moley
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

3.  Improved predictive test for MEN2, using flanking dinucleotide repeats and RFLPs.

Authors:  J R Howe; T C Lairmore; S K Mishra; S Dou; R Veile; S A Wells; H Donis-Keller
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

4.  The mutation for medullary thyroid carcinoma with parathyroid tumors (MTC with PTs) is closely linked to the centromeric region of chromosome 10.

Authors:  N L Carson; J S Wu; C E Jackson; K K Kidd; N E Simpson
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

5.  The genetic defect in multiple endocrine neoplasia type 2A maps next to the centromere of chromosome 10.

Authors:  J S Wu; N L Carson; S Myers; A J Pakstis; J R Kidd; C M Castiglione; L Anderson; L S Hoyle; M Genel; M Verdy
Journal:  Am J Hum Genet       Date:  1990-03       Impact factor: 11.025

6.  Deletion mapping of chromosome 1p and 22q in pheochromocytoma.

Authors:  E Shin; S Fujita; K Takami; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1993-04

7.  Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.

Authors:  I Yana; T Nakamura; E Shin; K Karakawa; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.